JPM: Why hasn't Merck been making deals? It's not for lack of trying, CEO says

There’s a reason Merck hasn’t made a big acquisition lately. And it’s not because it doesn’t want to.

“We’re very active,” CEO Ken Frazier said during a Monday afternoon fireside chat at the J.P. Morgan Healthcare Conference, adding “the fact that you haven’t seen a large deal coming out of Merck recently is not reflective of the fact that we’re not looking at those large acquisitions.”